Literature DB >> 22464684

Semisynthetic neoclerodanes as kappa opioid receptor probes.

Kimberly M Lovell1, Tamara Vasiljevik, Juan J Araya, Anthony Lozama, Katherine M Prevatt-Smith, Victor W Day, Christina M Dersch, Richard B Rothman, Eduardo R Butelman, Mary Jeanne Kreek, Thomas E Prisinzano.   

Abstract

Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464684      PMCID: PMC3344910          DOI: 10.1016/j.bmc.2012.02.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  45 in total

Review 1.  Recent advances in selective opioid receptor agonists and antagonists.

Authors:  Masakatsu Eguchi
Journal:  Med Res Rev       Date:  2004-03       Impact factor: 12.944

2.  The therapeutic potential of κ-opioids for treatment of pain and addiction.

Authors:  Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

3.  Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.

Authors:  Cécile Béguin; Justin Potuzak; Wei Xu; Lee-Yuan Liu-Chen; John M Streicher; Chad E Groer; Laura M Bohn; William A Carlezon; Bruce M Cohen
Journal:  Bioorg Med Chem Lett       Date:  2011-12-07       Impact factor: 2.823

4.  Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.

Authors:  Feng Yan; Philip D Mosier; Richard B Westkaemper; Jeremy Stewart; Jordan K Zjawiony; Timothy A Vortherms; Douglas J Sheffler; Bryan L Roth
Journal:  Biochemistry       Date:  2005-06-21       Impact factor: 3.162

5.  Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.).

Authors:  L J Valdés; J L Díaz; A G Paul
Journal:  J Ethnopharmacol       Date:  1983-05       Impact factor: 4.360

Review 6.  Interactions between kappa opioid agonists and cocaine. Preclinical studies.

Authors:  N K Mello; S S Negus
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

7.  A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.

Authors:  Kevin Tidgewell; Wayne W Harding; Mark Schmidt; Kenneth G Holden; Daryl J Murry; Thomas E Prisinzano
Journal:  Bioorg Med Chem Lett       Date:  2004-10-18       Impact factor: 2.823

8.  Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.

Authors:  Yulin Wang; Kang Tang; Saadet Inan; Daniel Siebert; Ulrike Holzgrabe; David Y W Lee; Peng Huang; Jian-Guo Li; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2004-09-21       Impact factor: 4.030

9.  Facile microwave-mediated transformations of 2-butene-1,4-diones and 2-butyne-1,4-diones to furan derivatives.

Authors:  H Surya Prakash Rao; S Jothilingam
Journal:  J Org Chem       Date:  2003-06-27       Impact factor: 4.354

10.  Concise syntheses of coronarin A, coronarin E, austrochaparol and pacovatinin A.

Authors:  Takahiro Miyake; Keisuke Uda; Masako Kinoshita; Mikio Fujii; Hiroyuki Akita
Journal:  Chem Pharm Bull (Tokyo)       Date:  2008-03       Impact factor: 1.645

View more
  11 in total

Review 1.  Clerodane diterpenes: sources, structures, and biological activities.

Authors:  Rongtao Li; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2016-07-18       Impact factor: 13.423

Review 2.  Neoclerodanes as atypical opioid receptor ligands.

Authors:  Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

3.  LC-MS/MS quantification of salvinorin A from biological fluids.

Authors:  Michael J Caspers; Todd D Williams; Kimberly M Lovell; Anthony Lozama; Eduardo R Butelman; Mary Jeanne Kreek; Matthew Johnson; Roland Griffiths; Katherine Maclean; Thomas E Prisinzano
Journal:  Anal Methods       Date:  2013-12-21       Impact factor: 2.896

Review 4.  A review of salvinorin analogs and their kappa-opioid receptor activity.

Authors:  Jeremy J Roach; Ryan A Shenvi
Journal:  Bioorg Med Chem Lett       Date:  2018-03-12       Impact factor: 2.823

5.  Nickel-Catalyzed Suzuki-Miyaura Coupling of Aliphatic Amides.

Authors:  Timothy B Boit; Nicholas A Weires; Junyong Kim; Neil K Garg
Journal:  ACS Catal       Date:  2017-12-20       Impact factor: 13.084

Review 6.  Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

Authors:  Bronwyn M Kivell; Amy W M Ewald; Thomas E Prisinzano
Journal:  Adv Pharmacol       Date:  2014

7.  Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.

Authors:  Prabhakar R Polepally; Kate White; Eyal Vardy; Bryan L Roth; Daneel Ferreira; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

8.  Palladium-catalyzed transformations of salvinorin A, a neoclerodane diterpene from Salvia divinorum.

Authors:  Andrew P Riley; Victor W Day; Hernán A Navarro; Thomas E Prisinzano
Journal:  Org Lett       Date:  2013-11-18       Impact factor: 6.005

9.  Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists.

Authors:  Alyssa M Hartung; John A Beutler; Hernán A Navarro; David F Wiemer; Jeffrey D Neighbors
Journal:  J Nat Prod       Date:  2014-01-23       Impact factor: 4.050

Review 10.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.